Sven Michel
Head of Bioinformatics at Secarna Pharmaceuticals
📍 Greater Munich Metropolitan Area, Germany
Dr. Sven Michel is the Head of Bioinformatics at Secarna Pharmaceuticals, specializing in next-generation antisense oligonucleotide (ASO) therapies. He leads the advancement of the companys proprietary bioinformatics platform and holds a Dr. rer. nat. from Hannover Medical School and a diploma from the Technical University of Munich.
He is a key inventor on patents related to antisense oligonucleotides for tumor treatment and has presented his research on ASO activity and targetability at international conferences.
Read the full overview →Experience
11 Years
Current Role
Head of Bioinformatics
Job Level
Mid-senior
Location
Greater Munich Metropolitan Area, Germany
Personality Overview
Personality insights not availableWe need more social data to generate the DISC analysis and selling playbook. The professional details below are still available.
Priorities
Topics Sven cares about
ASO Drug Discovery
He leads the bioinformatics platform at Secarna specifically designed for identifying and developing antisense oligonucleotide (ASO) therapies.
Bioinformatics Platforms
His work involves the ongoing optimization and use of Secarna's proprietary Oligofyer™ bioinformatics system for drug discovery.
Career
Work history
2-2022
Head of Bioinformatics
Secarna Pharmaceuticals
12-2015
Scientist Bioinformatics
Secarna Pharmaceuticals
4-2014 - 12-2015
Bioinformatiker
DIS AG
In the press
Media appearances
No media yetWe could not find public media appearances for this person.
Education
Dr. rer. nat.
Medizinische Hochschule Hannover
Dipl. Bioinf.
Technische Universität München / Ludwig-Maximilians Universität München
Social presence
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.